Literature DB >> 2382156

Diabetes mellitus as a risk factor for stroke.

K F Mortel1, J S Meyer, P A Sims, K McClintic.   

Abstract

To evaluate the relative potency of diabetes mellitus as a risk factor for stroke, the relative frequency of stroke symptoms was compared among cohorts with and without diabetes. Stroke symptoms were classified as atherothrombotic cerebral infarctions, transient ischemic attacks, reversible ischemic neurologic deficits, and multi-infarct dementia. The groups were compared according to the occurrence of these symptoms, and both cross-sectional and longitudinal designs were used to study 293 consecutive patients referred to this laboratory and to contrast groups with and without diabetes. Hypertension, heart disease, and stroke symptoms and signs were more frequent among diabetics than among age-matched nondiabetics. Among diabetics, strokes occurred at an earlier age and were more common among men. Regression analyses assigned diabetes second to hypertension as a risk factor for stroke, followed by heart disease and smoking. Diabetes associated with hypertension or hyperlipidemia added significantly to stroke risk. Initially, cerebral blood flow values and cognitive test scores were equivalent among diabetics and nondiabetics; after 3 years, cognition became significantly impaired among diabetics, despite better maintenance of cerebral blood flow among treated diabetics compared with nondiabetics. Diabetes acts to compound risk for stroke not only by promoting cerebral atherogenesis but also by aggravating other risk factors including hypertension, heart disease, and hyperlipidemia.

Entities:  

Mesh:

Year:  1990        PMID: 2382156     DOI: 10.1097/00007611-199008000-00014

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

1.  Losartan improves impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type 1 diabetic rats.

Authors:  Denise M Arrick; Glenda M Sharpe; Hong Sun; William G Mayhan
Journal:  Brain Res       Date:  2008-03-21       Impact factor: 3.252

2.  Ultrasonic evaluation with second harmonic imaging and SonoVue in the assessment of cerebral perfusion in diabetic patients: a case-control study.

Authors:  Giuseppe Caruso; Giuseppe Salvaggio; Pietro Ragusa; Giuseppe Brancatelli; Roberto Lagalla
Journal:  Eur Radiol       Date:  2004-09-11       Impact factor: 5.315

3.  Intelligent data analysis to interpret major risk factors for diabetic patients with and without ischemic stroke in a small population.

Authors:  Fikret Gürgen; Nurgül Gürgen
Journal:  Biomed Eng Online       Date:  2003-03-04       Impact factor: 2.819

4.  Laboratory tests as short-term correlates of stroke.

Authors:  Trevor Sughrue; Michael A Swiernik; Yang Huang; James P Brody
Journal:  BMC Neurol       Date:  2016-07-21       Impact factor: 2.474

5.  Antibody-Mediated Inhibition of Insulin-Degrading Enzyme Improves Insulin Activity in a Diabetic Mouse Model.

Authors:  Ofir Fursht; Mirit Liran; Yuval Nash; Vijay Krishna Medala; Dor Ini; Tabitha Grace Royal; Guy Goldsmith; Limor Nahary; Itai Benhar; Dan Frenkel
Journal:  Front Immunol       Date:  2022-03-08       Impact factor: 7.561

6.  A cannabinoid type 2 (CB2) receptor agonist augments NOS-dependent responses of cerebral arterioles during type 1 diabetes.

Authors:  Lauren Van Hove; Kirsten R Kim; Denise M Arrick; William G Mayhan
Journal:  Microvasc Res       Date:  2020-09-24       Impact factor: 3.514

7.  Examining the causal mediating role of brain pathology on the relationship between diabetes and cognitive impairment: the Cardiovascular Health Study.

Authors:  Ryan M Andrews; Ilya Shpitser; Oscar Lopez; William T Longstreth; Paulo H M Chaves; Lewis Kuller; Michelle C Carlson
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2020-05-08       Impact factor: 2.483

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.